# OnCo record paper-precision-mri-targeted-biopsy-nejm-2018 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-precision-mri-targeted-biopsy-nejm-2018/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-precision-mri-targeted-biopsy-nejm-2018" ;
  schema:name "PRECISION: MRI-targeted or standard biopsy for prostate cancer diagnosis"@en ;
  schema:description "Doing an MRI first and biopsying only suspicious areas found more clinically significant prostate cancers and fewer harmless ones than standard biopsy, while sparing a quarter of men any biopsy at all."@en ;
  schema:url <https://onco.cc/key-papers/paper-precision-mri-targeted-biopsy-nejm-2018/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1801993>, <https://pubmed.ncbi.nlm.nih.gov/29552975/> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1801993> ;
  schema:datePublished "2018"^^xsd:gYear ;
  schema:author "Kasivisvanathan V, Rannikko AS, Borghi M, et al." ;
  onco:related <https://onco.cc/roadmaps/prostate-roadmap/>, <https://onco.cc/key-papers/paper-ahmed-promis-multiparametric-mri-lancet-2017/>, <https://onco.cc/key-papers/paper-johnson-mpmri-individual-foci-eur-urol-2019/>, <https://onco.cc/ideas/idea-prostate-per-lesion-mri-audit-before-focal-treatment/> ;
  onco:cancers <https://onco.cc/cancers/prostate-low-risk/>, <https://onco.cc/cancers/prostate/> ;
  onco:terms <https://onco.cc/terms/pi-rads/>, <https://onco.cc/terms/template-mapping-biopsy/> ;
  onco:trials <https://onco.cc/trials/precision-mri/> ;
  onco:journals <https://onco.cc/journals/nejm/> .